Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.
(9ALJ621)
Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.
(9ALJ621)Crystal deal toy, incorporating an interior, 3-D etching of Thor’s hammer, commemorating a private placement by pharmaceutical company Photocure ASA. Based in Oslo, Norway, Photocure specializes in photodynamic therapies that make use of light-activated drugs.
(20LJW163)Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.
(20ALJ334)Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)Crystal deal toy commemorating a loan facility provided for Biohaven Pharmaceuticals, based in New Haven, Connecticut.
(20ALJ278)Deal tombstone recognizing a follow-on offering by Pennsylvania-based biotech firm Windtree Therapeutics.
(20AH070)Custom deal toy celebrating the initial public offering by South Korean firm SK Biopharmaceuticals. The listing on Seoul’s main stock exchange was the largest in South Korea since 2017. .
(20ALJ243)Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors.
(9AKL619)Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.
(20ALJ071)
